| Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy L Apetoh, F Ghiringhelli, A Tesniere, M Obeid, C Ortiz, A Criollo, G Mignot, ... Nature medicine 13 (9), 1050-1059, 2007 | 3430 | 2007 |
| Calreticulin exposure dictates the immunogenicity of cancer cell death M Obeid, A Tesniere, F Ghiringhelli, GM Fimia, L Apetoh, JL Perfettini, ... Nature medicine 13 (1), 54-61, 2007 | 3370 | 2007 |
| Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors F Ghiringhelli, L Apetoh, A Tesniere, L Aymeric, Y Ma, C Ortiz, ... Nature medicine 15 (10), 1170-1178, 2009 | 2098 | 2009 |
| Cancer despite immunosurveillance: immunoselection and immunosubversion L Zitvogel, A Tesniere, G Kroemer Nature reviews immunology 6 (10), 715-727, 2006 | 1838 | 2006 |
| Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death N Casares, MO Pequignot, A Tesniere, F Ghiringhelli, S Roux, N Chaput, ... The Journal of experimental medicine 202 (12), 1691-1701, 2005 | 1620 | 2005 |
| Elective surgery cancellations due to the COVID-19 pandemic: global predictive modelling to inform surgical recovery plans Journal of British Surgery 107 (11), 1440-1449, 2020 | 1558 | 2020 |
| Immunogenic death of colon cancer cells treated with oxaliplatin A Tesniere, F Schlemmer, V Boige, O Kepp, I Martins, F Ghiringhelli, ... Oncogene 29 (4), 482-491, 2010 | 1251 | 2010 |
| Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell death T Panaretakis, O Kepp, U Brockmeier, A Tesniere, AC Bjorklund, ... The EMBO journal 28 (5), 578-590, 2009 | 953 | 2009 |
| The anticancer immune response: indispensable for therapeutic success? L Zitvogel, L Apetoh, F Ghiringhelli, F André, A Tesniere, G Kroemer The Journal of clinical investigation 118 (6), 1991-2001, 2008 | 721 | 2008 |
| The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy L Apetoh, F Ghiringhelli, A Tesniere, A Criollo, C Ortiz, R Lidereau, ... Immunological reviews 220 (1), 47-59, 2007 | 700 | 2007 |
| Molecular characteristics of immunogenic cancer cell death A Tesniere, T Panaretakis, O Kepp, L Apetoh, F Ghiringhelli, L Zitvogel, ... Cell Death & Differentiation 15 (1), 3-12, 2008 | 569 | 2008 |
| Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis M Obeid, T Panaretakis, N Joza, R Tufi, A Tesniere, P Van Endert, ... Cell Death & Differentiation 14 (10), 1848-1850, 2007 | 568 | 2007 |
| Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle-and high-income countries BJA: British Journal of Anaesthesia 117 (5), 601-609, 2016 | 563 | 2016 |
| Restoration of the immunogenicity of cisplatin-induced cancer cell death by endoplasmic reticulum stress I Martins, O Kepp, F Schlemmer, S Adjemian, M Tailler, S Shen, ... Oncogene 30 (10), 1147-1158, 2011 | 450 | 2011 |
| Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity L Aymeric, L Apetoh, F Ghiringhelli, A Tesniere, I Martins, G Kroemer, ... Cancer research 70 (3), 855-858, 2010 | 427 | 2010 |
| The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death T Panaretakis, N Joza, N Modjtahedi, A Tesniere, I Vitale, M Durchschlag, ... Cell Death & Differentiation 15 (9), 1499-1509, 2008 | 422 | 2008 |
| Contribution of IL-17–producing γδ T cells to the efficacy of anticancer chemotherapy Y Ma, L Aymeric, C Locher, SR Mattarollo, NF Delahaye, P Pereira, ... Journal of Experimental Medicine 208 (3), 491-503, 2011 | 403 | 2011 |
| Immunogenic cancer cell death: a key-lock paradigm A Tesniere, L Apetoh, F Ghiringhelli, N Joza, T Panaretakis, O Kepp, ... Current opinion in immunology 20 (5), 504-511, 2008 | 368 | 2008 |
| The IKK complex contributes to the induction of autophagy A Criollo, L Senovilla, H Authier, MC Maiuri, E Morselli, I Vitale, O Kepp, ... The EMBO journal 29 (3), 619-631, 2010 | 364 | 2010 |
| Chemotherapy induces ATP release from tumor cells I Martins, A Tesniere, O Kepp, M Michaud, F Schlemmer, L Senovilla, ... Cell cycle 8 (22), 3723-3728, 2009 | 312 | 2009 |
Guido KroemerUniversité de Paris Cité, Hôpital Européen George Pompidou - AP-HP, Gustave Roussy Cancer CampusEmail verificata su inserm.fr